PennyStockPayCheck.com Rss

Featured Posts

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Eurozone crisis live: Japan's strong growth figures... PM Shinzo Abe's stimulus package could generate feelgood factor needed to end two decades of stagnant growthPhillip Inman

Read more

ASCO 2012 Live Blog — Sunday

Posted by admin | Posted on 04-06-2012

Category : Business

Tags: , , , , , , , , ,

ASCO 2012 Live Blog – Sunday

CHICAGO (TheStreet) –Welcome to TheStreet’s live-blog coverage of the American Society of Clinical Oncology (ASCO) annual meeting. It’s Sunday, the second full day of data presentations at the largest annual gathering of cancer drug researchers in the world.

On the schedule for today: ASCO’s big plenary session, highlighting some of the most newsworthy clinical data at the conference. Roche and ImmunoGen are in the plenary spotlight this year with data from the phase III study of T-DM1 in breast cancer. Also sharing the plenary stage is a study combining Roche’s Rituxan with Teva’s Treanda in lymphoma. …

Click to view a price quote on RHHBY.

See the article here: ASCO 2012 Live Blog — Sunday

Post to Twitter

ASCO 2012 Live Blog — Saturday

Posted by admin | Posted on 03-06-2012

Category : Business, Stocks

Tags: , , , , , , , , , , , , ,

ASCO 2012 Live Blog – Saturday

CHICAGO (TheStreet) –Welcome to TheStreet’s live-blog coverage of the American Society of Clinical Oncology (ASCO) annual meeting. It’s Saturday, the first full day of data presentations at the largest annual gathering of cancer drug researchers in the world.

On the schedule for today: This morning, Johnson & Johnson will be presenting results from the phase III study of Zytiga in “pre-chemo” prostate cancer patients. These data have significant commercial implications not only for J&J but also Medivation and Dendreon. Investors have been waiting for months to get their hands on these Zytiga data. …

Click to view a price quote on JNJ.

Click to research the Drugs industry.

See the rest here: ASCO 2012 Live Blog — Saturday

Post to Twitter

‘Mad Money’ Lightning Round: Bullish on Baxter

Posted by admin | Posted on 28-03-2012

Category : Stocks

Tags: , , , , , , , ,

To see the full “Mad Money” Recap, please click here.

…

Click to view a price quote on LF.

Click to research the Consumer Durables industry.

Read more: ‘Mad Money’ Lightning Round: Bullish on Baxter

Post to Twitter